Titlebook: Cardiovascular Biomarkers; Pathophysiology and David A. Morrow Book 2006 Humana Press 2006 cardiovascular.heart.heart disease.myocardial i

不能平静

兽皮

Dawdle

Cardiac Troponin for Risk Assessment and Management of Non-ST-Elevation Acute Coronary Syndromek assessment in patients with suspected of a non-ST-elevation acute coronary syndrome (NSTEACS). Cardiac troponin T and cardiac troponin I are ideal biochemical markers for the detection of myocardial necrosis in unstable patients who have repeated episodes of ischemia of varying intensity and sever

–FER

Exterior

figure

罗盘

Diastole

Cardiac Troponin in Conditions Other Than Acute Coronary Syndromes several clinical settings, increased cardiac troponin is associated with both short- and long-term adverse outcomes. In addition, mechanisms responsible for analytical false-positive cardiac troponin results are addressed.

congenial

Degradation of Cardiac Troponinsthough the most common use of these tests is the diagnosis of acute myocardial infarction, it has become clear that there are a large number of other disease entities capable of causing troponin release. The process of supply/demand imbalance is a part of many of these other pathophysiologies and, t

随意

Developing a Marker of Ischemiand prognostic tests. Inadvertent discharge of patients thought to be at low risk of ischemia but later found to have an ACS remains unacceptably high. Present tools (history, clinical examination, electrocardiogram, and biomarkers of necrosis) are not optimally sensitive for the identification of pa